BerGenBio ASA (LON: 0RU5)
London
· Delayed Price · Currency is GBP · Price in NOK
8.50
-0.21 (-2.46%)
Jan 17, 2025, 10:06 AM BST
BerGenBio ASA Revenue
BerGenBio ASA had revenue of 521.00K NOK in the twelve months ending September 30, 2024, up 33.93% year-over-year. In the year 2023, BerGenBio ASA had annual revenue of 354.00K, down -9.00%.
Revenue (ttm)
521.00K NOK
Revenue Growth
+33.93%
P/S Ratio
n/a
Revenue / Employee
32.56K NOK
Employees
16
Market Cap
24.07M GBP
Revenue Chart
* This company reports financials in NOK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
Dec 31, 2019 | 8.90M | 6.57M | 281.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |